Chongqing Zhifei Biological Products Co., Ltd. (SHE:300122)

Market Cap	31.22B -47.2%
Revenue (ttm)	8.75B -48.5%
Net Income	-14.78B
EPS	-6.18
Shares Out	2.39B
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	25,218,749
Open	12.50
Previous Close	12.90
Day's Range	12.50 - 13.09
52-Week Range	11.07 - 26.00
Beta	0.45
Analysts	Buy
Price Target	21.17 (+62.35%)
Earnings Date	Aug 18, 2026

About SHE:300122

Chongqing Zhifei Biological Products Co., Ltd., a biopharmaceutical company, engages in the research and development, production, sale, and distribution of vaccine and biological products in China. The company offers recombinant COVID-19 vaccine; recombinant mycobacterium tuberculosis fusion protein products; group A and C meningococcal polysaccharide vaccine; ACYW135 meningococcal polysaccharide vaccine; Haemophilus Influenza type B conjugate vaccine; mycobacterium injection under the Vaccae brand; and meningococcal group A and C conjugate vac...

• Industry: Biotechnology
• Sector: Healthcare
• Founded: 2002
• Employees: 6,292
• Stock Exchange: Shenzhen Stock Exchange
• Ticker Symbol: 300122

Analyst Summary

According to 3 analysts, the average rating for 300122 stock is "Buy." The 12-month stock price target is ¥21.17, which is an increase of 62.35% from the latest price.

Price Target

¥21.17

(62.35% upside)

Analyst Consensus: Buy

Data Sources: S&P Global Market Intelligence and Financial Modeling Prep

Fundamental and historical data is provided by S&P Global Market Intelligence. Delayed stock pricing data is provided by Financial Modeling Prep.

Last checked:

Jul 31, 2026

Data Sources Report a data error